|
Market Closed -
NSE India S.E.
15:05:10 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,860.00 INR | +1.69% |
|
+4.63% | +8.16% |
| 11-04 | India proposes instant manufacturing licence suspension for drugs failing quality tests | RE |
| 11-02 | Indian shares set for positive start on talks to end Iran war, strong Reliance earnings | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 47.48B | |||||
| 1,206B | |||||
| 665B | |||||
| 515B | |||||
| 381B | |||||
| 362B |
Select your edition
All financial news and data tailored to specific country editions
